{"id":"https://openalex.org/W7204496642","doi":"https://doi.org/10.1001/jamadermatol.2026.2043","title":"Drug Survival of Omalizumab and Factors Associated With Discontinuation in Chronic Urticaria: A Meta-Analysis","display_name":"Drug Survival of Omalizumab and Factors Associated With Discontinuation in Chronic Urticaria: A Meta-Analysis","publication_year":2026,"publication_date":"2026-09-09","ids":{"openalex":"https://openalex.org/W7204496642","doi":"https://doi.org/10.1001/jamadermatol.2026.2043","pmid":"https://pubmed.ncbi.nlm.nih.gov/42714921","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13559732"},"language":"en","primary_location":{"id":"doi:10.1001/jamadermatol.2026.2043","doi":"https://doi.org/10.1001/jamadermatol.2026.2043","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamadermatol.2026.2043","pdf_url":null,"source":{"id":"https://openalex.org/S146641495","display_name":"JAMA Dermatology","issn_l":"2168-6068","issn":["2168-6068","2168-6084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13559732/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120589267","display_name":"Alhasan Altayf","orcid":"https://orcid.org/0009-0002-4905-8775","observed_orcids":["https://orcid.org/0009-0002-4905-8775"]},"institutions":[{"id":"https://openalex.org/I4405258300","display_name":"Azzaytuna University","ror":"https://ror.org/00ehj1e38","country_code":"LY","type":"education","lineage":["https://openalex.org/I4405258300"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Alhasan Altayf","raw_affiliation_strings":["Faculty of Medicine, Azzaytuna University, Tarhuna, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, Azzaytuna University, Tarhuna, Libya","institution_ids":["https://openalex.org/I4405258300"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011138906","display_name":"Pavel Kolkhir","orcid":"https://orcid.org/0000-0001-5380-8132","observed_orcids":["https://orcid.org/0000-0001-5380-8132"]},"institutions":[{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I4210107844","display_name":"Fraunhofer Institute for Translational Medicine and Pharmacology","ror":"https://ror.org/01s1h3j07","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210107844","https://openalex.org/I4923324"]},{"id":"https://openalex.org/I4210139777","display_name":"Berlin Institute of Health at Charit\u00e9 - Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/0493xsw21","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210139777","https://openalex.org/I7877124"]},{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Pavel Kolkhir","raw_affiliation_strings":["Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany","Institute of Allergology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany","institution_ids":["https://openalex.org/I4210107844"]},{"raw_affiliation_string":"Institute of Allergology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I4210139777","https://openalex.org/I75951250","https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140134941","display_name":"Mukhtar Alwefati","orcid":"https://orcid.org/0009-0008-8643-1907","observed_orcids":["https://orcid.org/0009-0008-8643-1907"]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Mukhtar Alwefati","raw_affiliation_strings":["Faculty of Medicine, University of Tripoli, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Tripoli, Tripoli, Libya","institution_ids":["https://openalex.org/I23906160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084120831","display_name":"Pedro Mendes\u2010Bastos","orcid":"https://orcid.org/0000-0002-2439-920X","observed_orcids":["https://orcid.org/0000-0002-2439-920X"]},"institutions":[{"id":"https://openalex.org/I4403386557","display_name":"Hospital CUF Descobertas","ror":"https://ror.org/05gsnx339","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4403386557"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Pedro Mendes-Bastos","raw_affiliation_strings":["Dermatology Center, Hospital CUF Descobertas, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Center, Hospital CUF Descobertas, Lisbon, Portugal","institution_ids":["https://openalex.org/I4403386557"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151018679","display_name":"Ranad Jirafa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I23906160","display_name":"University of Tripoli","ror":"https://ror.org/00taa2s29","country_code":"LY","type":"education","lineage":["https://openalex.org/I23906160"]}],"countries":["LY"],"is_corresponding":false,"raw_author_name":"Ranad Jirafa","raw_affiliation_strings":["Faculty of Medicine, University of Tripoli, Tripoli, Libya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of Tripoli, Tripoli, Libya","institution_ids":["https://openalex.org/I23906160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004878337","display_name":"Torsten Zuberbier","orcid":"https://orcid.org/0000-0002-1466-8875","observed_orcids":["https://orcid.org/0000-0002-1466-8875"]},"institutions":[{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I4210107844","display_name":"Fraunhofer Institute for Translational Medicine and Pharmacology","ror":"https://ror.org/01s1h3j07","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210107844","https://openalex.org/I4923324"]},{"id":"https://openalex.org/I4210139777","display_name":"Berlin Institute of Health at Charit\u00e9 - Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/0493xsw21","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210139777","https://openalex.org/I7877124"]},{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Torsten Zuberbier","raw_affiliation_strings":["Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany","Institute of Allergology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany","institution_ids":["https://openalex.org/I4210107844"]},{"raw_affiliation_string":"Institute of Allergology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Freie Universit\u00e4t Berlin, Humboldt-Universit\u00e4t zu Berlin, and Berlin Institute of Health, Berlin, Germany","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I4210139777","https://openalex.org/I75951250","https://openalex.org/I7877124"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041903193","display_name":"Muhammed Elhadi","orcid":"https://orcid.org/0000-0001-6406-4212","observed_orcids":["https://orcid.org/0000-0001-6406-4212"]},"institutions":[{"id":"https://openalex.org/I197347611","display_name":"Korea University","ror":"https://ror.org/047dqcg40","country_code":"KR","type":"education","lineage":["https://openalex.org/I197347611"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Muhammed Elhadi","raw_affiliation_strings":["College of Medicine, Korea University, Anam-ro, Seongbuk-gu, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine, Korea University, Anam-ro, Seongbuk-gu, Seoul, South Korea","institution_ids":["https://openalex.org/I197347611"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"162","issue":"10","first_page":"1046","last_page":"1046"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/umab","display_name":"umab","score":0.8790000081062317},{"id":"https://openalex.org/keywords/chronic-urticaria","display_name":"chronic urticaria","score":0.9890000224113464},{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":0.8960000276565552},{"id":"https://openalex.org/keywords/chronic-inducible-urticaria","display_name":"chronic inducible urticaria","score":0.9760000109672546},{"id":"https://openalex.org/keywords/drug-survival","display_name":"drug retention","score":0.9589999914169312},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.9210000038146973},{"id":"https://openalex.org/keywords/predictors-of-discontinuation","display_name":"predictors of discontinuation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/autoimmune-comorbidity","display_name":"autoimmune disease comorbidity","score":0.9800000190734863},{"id":"https://openalex.org/keywords/atopy","display_name":"atopy","score":0.8510000109672546},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4519999921321869},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.5389999747276306},{"id":"https://openalex.org/keywords/hazard-ratio","display_name":"hazard ratio","score":0.36500000953674316},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.5379999876022339},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7179999947547913},{"id":"https://openalex.org/keywords/anti-ige-therapy","display_name":"anti-IgE therapy","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9204999804496765},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9169999957084656},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.9160000085830688},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.6373999714851379},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5992000102996826},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5706999897956848},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5615000128746033},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5471000075340271},{"id":"https://openalex.org/C3017745231","wikidata":"https://www.wikidata.org/wiki/Q187440","display_name":"Chronic urticaria","level":2,"score":0.4927000105381012},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.4875999987125397},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.3765000104904175},{"id":"https://openalex.org/C2777466982","wikidata":"https://www.wikidata.org/wiki/Q5227287","display_name":"Data extraction","level":3,"score":0.3578999936580658},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3562000095844269},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.3138999938964844},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3084000051021576},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3057999908924103},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2921999990940094},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.28369998931884766},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2635999917984009},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.26330000162124634}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000080223","descriptor_name":"Chronic Urticaria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1001/jamadermatol.2026.2043","doi":"https://doi.org/10.1001/jamadermatol.2026.2043","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jamadermatol.2026.2043","pdf_url":null,"source":{"id":"https://openalex.org/S146641495","display_name":"JAMA Dermatology","issn_l":"2168-6068","issn":["2168-6068","2168-6084"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Dermatology","raw_type":"journal-article"},{"id":"pmid:42714921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42714921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA dermatology","raw_type":"Journal Article"},{"id":"pmh:oai:publica.fraunhofer.de:publica/522876","doi":null,"is_oa":false,"landing_page_url":"https://publica.fraunhofer.de/handle/publica/522876","pdf_url":null,"source":{"id":"https://openalex.org/S4306400318","display_name":"Fraunhofer-Publica (Fraunhofer-Gesellschaft)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4923324","host_organization_name":"Fraunhofer-Gesellschaft","host_organization_lineage":["https://openalex.org/I4923324"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13559732","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13559732/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA Dermatol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13559732","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13559732/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAMA Dermatol","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1748713341","https://openalex.org/W2065102869","https://openalex.org/W2082977560","https://openalex.org/W2121663010","https://openalex.org/W2736673906","https://openalex.org/W2794972031","https://openalex.org/W2810953097","https://openalex.org/W2907997108","https://openalex.org/W3112552650","https://openalex.org/W3118615836","https://openalex.org/W3126817223","https://openalex.org/W3163923489","https://openalex.org/W3200862524","https://openalex.org/W3215882371","https://openalex.org/W4210278448","https://openalex.org/W4213444127","https://openalex.org/W4226238994","https://openalex.org/W4239364114","https://openalex.org/W4281680487","https://openalex.org/W4293072745","https://openalex.org/W4321113915","https://openalex.org/W4321434442","https://openalex.org/W4381952162","https://openalex.org/W4386247323","https://openalex.org/W4389628328","https://openalex.org/W4400732620","https://openalex.org/W4402763277","https://openalex.org/W4402859333","https://openalex.org/W4406775204","https://openalex.org/W4408244065","https://openalex.org/W4410322872","https://openalex.org/W4410757143","https://openalex.org/W4411520089","https://openalex.org/W4411842124","https://openalex.org/W4412788645","https://openalex.org/W4417027278","https://openalex.org/W7106257832","https://openalex.org/W7124141305","https://openalex.org/W7127997606","https://openalex.org/W7128162672"],"related_works":["https://openalex.org/W4400732620","https://openalex.org/W7000229690","https://openalex.org/W4386247323","https://openalex.org/W7162099419","https://openalex.org/W2907997108","https://openalex.org/W4410322872","https://openalex.org/W7134050228","https://openalex.org/W4402763277","https://openalex.org/W4293679201","https://openalex.org/W4403215629"],"abstract_inverted_index":{"Importance:":[0],"Omalizumab":[1],"is":[2],"a":[3,122,137,212,222,273],"recommended":[4],"second-line":[5],"therapy":[6],"for":[7,87,102,146,165,203,221,364],"chronic":[8,193,236],"urticaria":[9,195,238],"(CU),":[10],"yet":[11],"clinical":[12,30,75],"evidence":[13],"regarding":[14],"long-term":[15,39,319],"drug":[16,25,40,84,161,201,231,320,343],"survival":[17,26,41,85,97,105,162,202,232,321],"and":[18,32,48,58,111,149,155,163,305,313],"determinants":[19],"of":[20,42,60,104,171,224,276,281,298,309,349],"discontinuation":[21,82,254,277,299,325,357],"remains":[22],"limited.":[23],"Understanding":[24],"patterns":[27],"may":[28],"inform":[29],"decision-making":[31],"patient":[33],"stratification.":[34],"Objective:":[35],"To":[36],"evaluate":[37],"the":[38,127,142,362],"omalizumab":[43,88,204,317],"in":[44,89,126,235,245,322],"patients":[45,90,184,216],"with":[46,52,91,176,185,192,272,294,324,341,356],"CU":[47,92,186],"identify":[49],"factors":[50],"associated":[51,271,293,340,355],"discontinuation.":[53,166],"Data":[54,109],"Sources:":[55],"PubMed,":[56],"Embase,":[57],"Web":[59],"Science":[61],"were":[62,93,107,115,134,197,339,354],"systematically":[63],"searched":[64],"from":[65,117],"database":[66],"inception":[67],"to":[68,81,218,258,263,279,301,329,347],"January":[69],"20,":[70],"2026.":[71],"Study":[72],"Selection:":[73],"Observational":[74],"studies":[76,181],"that":[77,316],"reported":[78],"on":[79],"time":[80],"or":[83,99,240],"outcomes":[86,158,168],"included.":[94,198],"Studies":[95],"lacking":[96],"data":[98,114],"sufficient":[100],"information":[101],"reconstruction":[103],"curves":[106,120],"excluded.":[108],"Extraction":[110],"Synthesis:":[112],"Time-to-event":[113],"reconstructed":[116],"published":[118],"Kaplan-Meier":[119],"using":[121,136],"validated":[123],"algorithm":[124],"implemented":[125],"IPDfromKM":[128],"framework.":[129],"Pooled":[130],"hazard":[131],"ratios":[132],"(HRs)":[133],"synthesized":[135],"random-effects":[138],"meta-analysis.":[139],"Analyses":[140],"followed":[141],"Preferred":[143],"Reporting":[144],"Items":[145],"Systematic":[147],"Reviews":[148],"Meta-Analyses":[150],"(PRISMA)":[151],"guidelines.":[152],"Main":[153],"Outcomes":[154],"Measures:":[156],"Primary":[157],"included":[159,169],"overall":[160],"reasons":[164],"Secondary":[167],"predictors":[170],"discontinuation,":[172],"expressed":[173],"as":[174],"HRs":[175],"95%":[177,285],"CIs.":[178],"Results:":[179],"Eight":[180],"comprising":[182],"4516":[183],"(3167":[187],"female":[188],"individuals":[189],"[70.1%];":[190],"3276":[191],"spontaneous":[194],"[CSU])":[196],"The":[199,307],"median":[200],"was":[205,255,266,270,292],"3.1":[206],"years":[207,226],"(95%":[208,227],"CI,":[209,228,286],"2.8-3.4).":[210],"Over":[211],"7-year":[213],"follow-up":[214],"period,":[215],"continued":[217],"receive":[219],"treatment":[220,367],"mean":[223],"3.75":[225],"3.62-3.87).":[229],"Long-term":[230],"appeared":[233],"higher":[234,274],"inducible":[237],"(with":[239],"without":[241],"concomitant":[242],"CSU)":[243],"than":[244,332],"CSU":[246],"alone":[247],"(7-year":[248],"survival,":[249,344],"43%-49%":[250],"vs":[251],"30%).":[252],"Early":[253],"primarily":[256,345],"due":[257,262,278,300,328,346],"well-controlled":[259,302],"disease.":[260,303],"Discontinuation":[261],"adverse":[264,333],"events":[265],"uncommon.":[267],"Autoimmune":[268,335],"comorbidity":[269],"risk":[275,297],"lack":[280,348],"efficacy":[282],"(HR,":[283],"2.03;":[284],"1.20-3.41),":[287],"while":[288],"an":[289,295],"atopic":[290,352],"background":[291],"increased":[296],"Conclusions":[304],"Relevance:":[306],"results":[308],"this":[310],"systematic":[311],"review":[312],"meta-analysis":[314],"suggest":[315],"demonstrates":[318],"CU,":[323],"more":[326],"often":[327],"disease":[330,359],"control":[331],"events.":[334],"comorbidities":[336,353],"(mainly":[337],"thyroid-related)":[338],"reduced":[342],"efficacy,":[350],"whereas":[351],"after":[358],"control,":[360],"underscoring":[361],"need":[363],"improved":[365],"endotype-driven":[366],"strategies.":[368]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-28T00:00:00"}